• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives

Recent Advances in the Study of 6-fluoro-2,3-dihydro-1H-Indol-1-amine (CAS: 120212-25-1): A Comprehensive Research Brief

In recent years, the compound 6-fluoro-2,3-dihydro-1H-Indol-1-amine (CAS: 120212-25-1) has garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique indole scaffold and fluorine substitution, has demonstrated promising potential in various therapeutic applications. The following research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and potential clinical applications.

The synthesis of 6-fluoro-2,3-dihydro-1H-Indol-1-amine has been optimized through several innovative approaches. Recent studies highlight the use of palladium-catalyzed cross-coupling reactions to introduce the fluorine atom at the 6-position of the indole ring, achieving higher yields and purity. Additionally, green chemistry methodologies have been employed to reduce environmental impact, emphasizing the pharmaceutical industry's shift toward sustainable practices.

From a biological perspective, 6-fluoro-2,3-dihydro-1H-Indol-1-amine has shown notable activity as a modulator of serotonin receptors. In vitro studies reveal its high affinity for the 5-HT_2A receptor, suggesting potential applications in neuropsychiatric disorders such as depression and anxiety. Furthermore, preliminary in vivo experiments in rodent models have demonstrated its ability to cross the blood-brain barrier efficiently, a critical factor for central nervous system-targeted therapies.

Recent investigations into the pharmacokinetic properties of this compound indicate favorable absorption and metabolic stability. Advanced analytical techniques, including LC-MS/MS, have been utilized to characterize its metabolic pathways, revealing minimal hepatotoxicity—a significant advantage for drug development. These findings position 6-fluoro-2,3-dihydro-1H-Indol-1-amine as a promising candidate for further preclinical evaluation.

In conclusion, the growing body of research on 6-fluoro-2,3-dihydro-1H-Indol-1-amine underscores its therapeutic potential and versatility. Continued exploration of its mechanisms of action and optimization of its pharmacological profile will be essential for translating these findings into clinical applications. This brief serves as a valuable resource for researchers and industry professionals seeking to stay abreast of developments in this rapidly evolving area of chemical biology.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)